Falsified lamivudine, zidovudine and nevirapine tablets (Zidolam - N) in Kenya
M
News
Points to consider for inspections of biowaiver data
M
The WHO Prequalification of Medicines Programme (PQP) intends to include in its inspection programme, sites that have performed comparative dissolution studies submitted in prod
Notice of concern (NOC) withdrawn for Bombay Bioresearch Center (BBRC), India
M
Following corrective actions taken by Bombay Bioresearch Center (BBRC) and the clarifications provided being considered acceptable, and considering the outcome of an additional inspe
Relenza Rotacap/Rotahaler removed from WHO List of Prequalified Medicinal Products
M
The Swedish Medical Product Ag
Revised WHO good practices for pharmaceutical quality control laboratories
M
The WHO Prequalification of Medicines Programme has posted on its website revised WHO Good Practices for Pharmaceutical Quality Control Laboratories, Annex 1 (WHO T
Notice of concern (NOC) withdrawn for Sandoz SA (Pty) Ltd, Kempton Park, South Africa
M
Following re-inspection of Sandoz SA (pty) Ltd, Kempton Park site in South Africa, the WHO Prequalification of Medicines Programme has
Requalification to start
M
In accordance with the provisions set out in sec
Notice of concern (NOC) withdrawn for Matrix Laboratories Ltd.
M
Following corrective actions taken by Matrix Laboratories Ltd and the clarifications provided being
WHO Medicines Prequalification Programme statement regarding Ranbaxy, Paonta Sahib, India manufacturing site
M
WHO is aware of the recent actions taken by the USA Food and Drug Administration (FDA) against the Ranbaxy, Paonta Sahib, India manufacturing site.
Creation of new WHO Public Inspection Report (WHOPIR) section: Archived WHOPIRs
M
As changes in manufacturing sites and activities on sites may change, it is suggested that all users of the list of prequalified products and WHOPIRs verify with the manufacturers
Ranbaxy products relisted and new Aurobindo products included in WHO's list of prequalified medicines
M
see also: WHO Media Centre: http://www.who.int/entity/mediacentre/news/notes/2005/n
Two Cipla AIDS medicines back on WHO's list of prequalified medicines: generic manufacturers continue to upgrade their practices
M
WHO News Release WHO/87, WHO Geneva.
Hetero Drugs Ltd. withdraws antiretrovirals from WHO prequalification list for further review
M
WHO, Geneva.
Ranbaxy withdraws all its antiretroviral medicines from WHO's list of prequalified products
M
WHO Geneva.
Removal of antiretroviral products from the WHO list of prequalified medicines
M
WHO Geneva. Department of Essential Drugs and Medicines Policy; Department of HIV/AIDS
Four news AIDS medicines added to WHO's list of prequalified medicines
M
New edition of WHO prequalification list to include four new anti-AIDS medicines; assessment reports to be made public in coming days
UN agency drops 2 drugs for AIDS care worldwide
M
From The New York Times, 16 June 2004
By Lawrence K. Alyman & Donald G. McNeil Jr.
Generic AIDS drugs on UN list
M
From The New York Times, Thursday, March 21, 2002
Inclusion of products is setback for pharmaceutical giants.
World Health Organization prepares list of 'quality' AIDS medication
M
From The Wall Street Journal, 20 March 2002
By Rachel Zimmerman
New list of safe AIDS drugs, despite industry lobby
M
From The New York Times Thursday, March 20, 2002
By Donald G. McNeil Jr.
Presentations 2024 Joint UNICEF-UNFPA-WHO Meeting available
ID
IVD
IS
M
V
VCP
The presentations of the 2024 Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers which took place from 2 to 6 December 2024 at UN City, Copenhagen, Denmark are now available at:
Long Term Agreement for WHO Prequalification Website Maintenance and Support - Withdrawn
ID
IVD
IS
M
V
VCP
UPDATE - Request for Proposals (RFP) Withdrawn for Internal Reasons
Workshop for African manufacturers of HIV RDTs
IVD
WHO Member States are increasingly stepping up to increase human resources and manufacturing capacities for local production.
Request for Proposals (RFP): Support to the WHO Immunization Devices and Equipment Prequalification Team
ID
The WHO Immunization Devices and Equipment Prequalification Team is seeking to enter into a contractual agreement with a successful bidder to implement the following work packages:
WHO to begin development of parallel recommendation and regulatory pathways; shortening the time taken for people to access health products
ID
IVD
IS
M
V
VCP
Ensuring access to quality-assured, safe and effective therapies is a core part of WHO’s mission.
Technical Specifications Series for WHO PQ of computer aided diagnosis of TB - for public comment (deadline 30 April 2024)
ID
IVD
IS
M
V
VCP
WHO Prequalification is inviting you to review the draft working document on Technical Specifications Series for submission to WHO Prequalification – Medical Device Assessment Screenin
Registration is open for Joint UNICEF-UNFPA-WHO Meeting with Manufacturers and Suppliers
ID
IVD
IS
M
V
VCP
for more information click here